RDFA
NBSE
Ritter Daniher Financial Advisory’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-2
| Closed | -$1 | – | 343 |
|
|
2023
Q1 | $1 | Hold |
2
| – | – | ﹤0.01% | 297 |
|
|
2022
Q4 | $0 | Buy |
+2
| New | – | ﹤0.01% | 310 |
|
|
2022
Q1 | – | Sell |
-2
| Closed | – | – | 268 |
|
|
2021
Q4 | $0 | Hold |
2
| – | – | ﹤0.01% | 260 |
|
|
2021
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 218 |
|
|
2021
Q2 | $0 | Hold |
2
| – | – | ﹤0.01% | 213 |
|
|
2021
Q1 | $0 | Hold |
2
| – | – | ﹤0.01% | 203 |
|
|
2020
Q4 | $0 | Buy |
+2
| New | – | ﹤0.01% | 189 |
|